MedTrace Logo

Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19

NCT06008444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2025-05-18

No results posted yet for this study

Summary

To comparative pain intensity, chest mobility, cough strength, muscle strength, physical activity levels and quality of life in Parkinson's patients with post-COVID-19 and without post-COVID-19 was aimed in current study. Knowledge in the literature regarding this topic is still obscure.

Conditions

  • COVID-19 Respiratory Infection
  • Parkinson Disease

Interventions

OTHER

Physical Evaluations of post-COVID-19 individuals

In this research, the data of Parkinson's patients who have had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

OTHER

Physical Evaluations of non-post-COVID-19 individuals

In this research, the data of Parkinson's patients who have not had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Sponsors & Collaborators

  • Izmir Democracy University

    lead OTHER

Principal Investigators

  • GÜLŞAH BARĞI · Izmir Democracy University

  • MERVE ŞAHİN · Izmir Democracy University

  • ÖZLEM ÇİNAR ÖZDEMİR · Izmir Democracy University

  • YASEMİN ÜNAL · Bandirma Health Practice and Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-13
Primary Completion
2024-08-30
Completion
2024-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06008444 on ClinicalTrials.gov